Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF

European Journal of Pharmacology

Volumn 691, Issue 1-3, 2012, Pages 134-142

  Zaitone, Sawsan A ^a   Abo Gresha, Noha M ^b  

^a Suez Canal University   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

Angiogenesis; iNOS; Myocardial infarction; Rat; Rosuvastatin; VEGF

Indexed keywords

CD34 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPRENALINE; ROSUVASTATIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL; UPREGULATION; VASCULOTROPIN BLOOD LEVEL;

ACUTE DISEASE; ANIMALS; BODY WEIGHT; ELECTROCARDIOGRAPHY; FLUOROBENZENES; HEART VENTRICLES; ISOPROTERENOL; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, COMPLEMENT 3B; SULFONAMIDES; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865004276     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.06.022     Document Type: Article

References (59)

1. S.K. Banerjee, S. Sood, and A.K. Dinda Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 136 2003 377 386 (Pubitemid 38167575)
2. I.J. Benjamin, J.E. Jalil, L.B. Tan, K. Cho, K.T. Weber, and W.A. Clark Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ. Res. 65 1989 657 670 (Pubitemid 19226442)
3. S.N. Buhl, and K.Y. Jackson Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin. Chem. 24 1978 828 831 (Pubitemid 8338630)
4. W.L. Chen, K.X. Ouyang, H.G. Li, Z.Q. Huang, J.S. Li, and J.G. Wang Expression of inducible nitric oxide synthase and vascular endothelial growth factor in ameloblastoma J. Craniofac. Surg. 20 2009 171 175
5. S. Donnini, and M. Ziche Constitutive and inducible nitric oxide synthase, role in angiogenesis Antioxid. Redox Signaling 4 2004 817 823
6. J. Dulak, A. Jozkowich, A. Dembinska-Kiec, I. Guevara, A. Zdzienicka, D. Zmudzinska-Grochot, I. Florek, A. Wójtowicz, A. Szuba, and J.P. Cooke Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells Thromb. Vasc. Biol. 20 1999 659 666
7. S.B. Freedman, and J.M. Isner Therapeutic angiogenesis for ischemic cardiovascular disease J. Mol. Cell Cardiol. 33 2001 379 393 (Pubitemid 32538996)
8. D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C. Yun, D.G. Buerk, P.L. Huang, and K. Rakesh Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc. Nat. Acad. Sci. U.S.A. 98 2001 2604 2609 (Pubitemid 32209529)
9. A. Garjani, S. Andalib, S. Biabani, H. Soraya, Y. Doustar, A. Garjani, and N. Maleki-Dizaji Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat Eur. J. Pharmacol. 666 2011 135 141
10. A. Gianella, E. Nobili, M. Abbate, C. Zoja, P. Gelosa, L. Mussoni, S. Bellosta, M. Canavesi, D. Rottoli, U. Guerrini, M. Brioschi, C. Banfi, E. Tremoli, G. Remuzzi, and L. Sironi Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats Am. J. Pathol. 170 2007 1165 1177 (Pubitemid 47339325)
11. Gong, L., Fang, L.H., Wang, S.B., Sun, J.L., Qin, H.L., Li, X.X., Wang, S.B., Du, G.H., 2012. Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol- induced myocardial infarction in rats. Atherosclerosis, in press.
12. S. Greisenegger, M. Mullner, S. Tentschert, W. Lang, and W. Lalouschek Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events J. Neurol. Sci. 221 2004 5 10 (Pubitemid 38721284)
13. J.-P. Guo, M.M. Panday, P.M. Consigny, and A.M. Lefer Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury Am. J. Physiol. 269 1995 H1122 H1131
14. B.A. Hamelin, and J. Turgeon Hydrophilicity/lipophilicity, relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors Trends Pharmacol. Sci. 19 1998 26 37 (Pubitemid 28094090)
15. Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes, a randomised placebo-controlled trial Lancet 361 2003 2005 2016
16. M. Heil, and W. Schaper Influence of mechanical, cellular and molecular factors on collateral artery growth (arteriogenesis) Circ. Res. 95 2004 449 458 (Pubitemid 39180925)
17. M. Iglarz, J.S. Silvestre, M. Duriez, D. Henrion, and B.I. Levy Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-NO pathway Arterioscler. Thromb. Vasc. Biol. 21 2001 1598 1603 (Pubitemid 34215578)
18. M. Imamura, K. Okunishi, H. Ohtsu, K. Nakagome, H. Harada, R. Tanaka, K. Yamamoto, and M. Dohi Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitization, interleukin 17 production and antigen presentation in the lung Thorax 64 2009 44 49
19. E.S. Istvan, and J. Deisenhofer Structural mechanism for statin inhibition of HMGCoA reductase Science 292 2001 1160 1164 (Pubitemid 32440937)
20. A.J. Kane, J.E. Barker, G.M. Mitchell, D.R.B. Theile, R. Romero, A. Messina, M. Wagh, F.O.G. Fraulin, W.A. Morrison, and A.G. Stewart Inducible nitric oxide synthase (iNOS) activity promotes ischemic skin flap survival Br. J. Pharmacol. 132 2001 1631 1638 (Pubitemid 32397954)
21. M.M. Kannan, and S. Darlin Quine Ellagic acid ameliorates isoproterenol induced oxidative stress, evidence from electrocardiological, biochemical and histological study Eur. J. Pharmacol. 45 2012 1 8
22. A.K. Kela, L.P. Reddy, and D.P. Thrombe ECG findings in normal rats and after administration of isoproterenol. Ind J. Physiol. Pharmacol. 24 1980 84 90 (Pubitemid 10013550)
23. P.A. Krijnen, R. Nijmeijer, and J.L.M. Meijer Apoptosis in myocardial ischemia and infarction J. Clin. Pathol. 55 2002 801 811
24. J. Kroll VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR) Biochem. Biophys. Res. Commun. 252 1998 743 746 (Pubitemid 28556847)
25. Y.T. Lau, and W.C. Ma Nitric oxide inhibits migration of cultured endothelial cells Biochem. Biophys. Res. Commun. 221 1996 670 674
26. M.R. Law, N.J. Wald, and A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke, systematic review and meta-analysis BMJ 326 2003 1423
27. S.H. Lee, P.L. Wolf, R. Escudero, R. Deutsch, S.W. Jamieson, and P.A. Thistlethwaite Early expression of angiogenesis factors in acute myocardial ischemia and infarction N. Engl. J. Med. 342 2000 626 633 (Pubitemid 30118415)
28. O.J. Liakopoulos, H. Dorge, J.D. Schmitto, U. Nagorsnik, J. Grabedünkel, and F.A. Schoendube Effects of preoperative statin therapy on cytokines after cardiac surgery Thorac. Cardiovasc. Surg. 54 2006 250 254 (Pubitemid 43937759)
29. J.K. Liao Statin therapy for cardiac hypertrophy and heart failure J. Investig. Med. 52 2004 248 253 (Pubitemid 39360341)
30. M. Liu, F. Wang, Y. Wang, and R. Jin Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy, the role of inflammation Cardiovasc. Drugs Ther. 23 2009 369 376
31. P.G. Lloyd, H.T. Yang, and R.L. Terjung Arteriogenesis and angiogenesis in rat ischemic hindlimb, role of nitric oxide Am. J. Physiol. Heart Circ. Physiol. 281 2000 H2528 H2538
32. M. Milkiewicz, E. Ispanovic, J.L. Doyle, and T.L. Haas Regulators of angiogenesis and strategies for their therapeutic manipulation Int. J. Biochem. Cell Biol. 38 2006 333 357 (Pubitemid 41821882)
33. K. Mizuno, N. Nakaya, Y. Ohashi, N. Tajima, T. Kushiro, T. Teramoto, S. Uchiyama, H. Nakamura MEGA Study Group Usefulness of pravastatin in primary prevention of cardiovascular events in women, analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study) Circulation 117 2008 494 502
34. C. Morgan, M. Zappitelli, and P. Gill Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass, a systematic review Crit. Care 13 2009 R165
35. T. Namba, H. Koike, K. Murakami, M. Aoki, H. Makino, N. Hashiya, T. Ogihara, Y. Kaneda., M. Kohno, and R. Morishita Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model Circulation 108 2003 2250 2257 (Pubitemid 37363043)
36. S. Nematollahi, M. Nematbakhsh, S. Haghjooyjavanmard, M. Khazaei, and M. Salehi Inducible nitric oxide synthase modulates angiogenesis. In: ischemic hindlimb of rat 153 2009 125 130 Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 153 2009 125 130
37. A. Papapetropoulos, K.M. Desai, R.D. Rudic, M.R. Zhang, M.P. Ruiz-Torres, G. García-Cardeña, J.A. Madri, and W.C. Sessa Nitric oxide synthase inhibitors attenuate transforming-growth-factor-b1-stimulated capillary organization in vitro Am. J. Pathol. 150 1997 1835 1844 (Pubitemid 27193829)
38. V. Patel, A. Upaganlawar, R. Zalawadia, and R. Balaraman Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats, a biochemical, electrocardiographic and histoarchitectural evaluation Eur. J. Pharmacol. 644 2010 160 168
39. E. Pipili-Synetos, E. Sakkoula, and M.E. Maragoudakis Nitric oxide is involved in the regulation of angiogenesis Br. J. Pharmacol. 108 1993 855 857 (Pubitemid 23102198)
40. E. Pipili-Synetos, E. Sakkoula, and G. Haralabopoulos Evidence that nitric oxide is an endogenous antiangiogenic mediator Br. J. Pharmacol. 111 1994 894 902 (Pubitemid 24151681)
41. E. Pipili-Synetos, S. Kritikou, E. Papadimitriou, A. Athanassiadou, C. Flordellis, and M.E. Maragoudakis Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane Br. J. Pharmacol. 129 2000 207 213 (Pubitemid 30072689)
42. A. RayChaudhury, H. Frischer, and A.B. Malik Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide J. Cell Biochem. 63 1996 125 134 (Pubitemid 26374252)
43. S.W. Ryter, J. Alam, and A.M. Choi Heme oxygenase-1/carbon monoxide, from basic science to therapeutic applications Physiol. Rev. 86 2006 583 650
44. M. Sata, H. Nishimatsu, E. Suzuki, S. Sugiura, M. Yoshizumi, Y. Ouchi, Y. Hirata, and R. Nagai Endothelial nitric oxide synthase is essential for the HMG CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia FASEB J. 15 2001 2530 2532
45. A.M. Shah, and C.L. Wainwright Paracrine and autocrine effects of nitric oxide on myocardial function Pharmacol. Therapeut. 2000 86 2000 49 86 (Pubitemid 30173144)
46. Y. Shen, H. Wu, C. Wang, H. Shao, H. Huang, H. Jing, and D. Li Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor γ Eur. J. Pharmacol. 649 2010 255 262
47. F.Q. Sheng, R. Xu, L.X. Cheng, Q.T. Zeng, W. Gao, W. Wang, S.Y. Dang, C.Q. Wang, and C.R. He In rats with myocardial infarction, interference by simvastatin with the TLR4 signal pathway attenuates ventricular remodelling Acta Cardiol. 64 2009 779 785
48. M. Shyamsundar, S.T. McKeown, C.M. O'Kane, T.R. Craig, V. Brown, D.R. Thickett, M.A. Matthay, C.C. Taggart, J.T. Backman, J.S. Elborn, and D.F. McAuley Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers Am. J. Respir. Crit. Care Med. 179 2009 1107 1114
49. S. Srivastava, B. Chandrasekar, Y. Gu, J. Luo, T. Hamid, B.G. Hill, and S.D. Prabhu Downregulation of CuZn-superoxide dismutase contributes to betaadrenergic receptor-mediated oxidative stress in the heart Cardiovasc. Res. 74 2007 445 455 (Pubitemid 46693706)
50. Szasz, G., 1975. Proceedings of the Second International Symposium on Clinical Enzymology. Chicago, IL, USA.
51. H. Tuby, L. Maltz, and U. Oron Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis Lasers Surg. Med. 38 2006 682 688 (Pubitemid 44300942)
52. G.A. Vogler Anesthesia and analgesia M.A. Suckow, S.H. Weisbroth, C.L. Franklin, The Laboratory Rat 2006 Elsevier Academic Press New York, USA 627 695
53. N.S. Wayman, B.L. Ellis, and C. Thiemermann Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat Med. Sci. Monit. 9 2003 BR155 BR159
54. U. Wurzburg, N. Hennrich, and H. Lang Bestimmung der Aktivität von creatinkinase MB in serum unter verwendung inhibierender antikörper Klin. Wochenschr. 54 1976 357
55. L. Xi, N.C. Jarrett, M.L. Hess, and R.C. Kukreja Essential role of inducible nitric oxide synthase in monophosphoryl a induced late cardioprotection Circulation 99 1999 157 163
56. J. Xu, X. Liu, J. Chen, A. Zacharek, X. Cui, S. Savant-Bhonsale, Z. Liu, and M. Chopp Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway Am. J. Physiol. Cell Physiol. 296 2009 C535 C543
57. I. Zachary, and G. Gliki Signaling transduction mechanisms mediating biological action of the vascular endothelial growth factor family Cardiovasc. Res. 49 2001 568 581 (Pubitemid 32146420)
58. M. Ziche, L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggi, P. Geppetti, and F. Ledda Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94 1994 2036 2044 (Pubitemid 24348244)
59. M. Ziche, L. Morbidelli, R. Choudhuri, H.T. Zhang, S. Donnini, H.J. Granger, and R. Bicknell Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor induced angiogenesis J. Clin. Invest. 99 1997 2625 2634 (Pubitemid 27259809)